For example,
Should we still worry about new: Furthermore. However,
Should we still worry about:
A new study calls into question that the taking of valproate in the father. Furthermore, three months before design, would increase the risk of neurodevelopmental disorders in the unborn children.
Since January 2025. Moreover. Furthermore, the prescription of Valproate and its derivatives (Dépakine, Micropakine, Dépakote, Divalcote, Dépamé and Generic), in men too, is reserved for neurologists, psychiatrists or pediatricians, with a possible renewal by any doctor. In addition. for each deliverance. these men must present with the prescription a certificate of shared information co-signed with the doctor, valid for one year. However, these measures could ultimately be lifted. Indeed. they were implemented following the publication of a post-AMM study carried out by the manufacturers. from data from registers in Denmark, Norway and Sweden. Work that suggested a slight increase in the risk should we still worry about new of neurodevelopmental disorders in children whose father had been treated. should we still worry about by ValProate within three months before design.
But today, a new post-AMM study does not raise this increase in risk in children to be born. The latter used a subset of data from the first study (Denmark data) and aimed to find the same results. Which was not the case. On the contrary. the results did not suggest any association between the use of valproate by the father. an increased risk of neurodevelopmental disorders in children.
For the moment. nothing changes on the driving to be taken: among men. the first prescription remains reserved for specialists and the certificate of shared information must be presented with each deliverance. Nevertheless. “The European Medicines Agency (EMA) has launched a procedure in order to understand the difference between the results of the studies. intends to request should we still worry about new additional information and analyzes from the laboratories holding AMM for the valproate “, should we still worry about Specifies the National Agency for the Safety of Medicines and Health Products (ANSM).
Should we still worry about new
Should we still worry about
Further reading: Type I SMA: a new genes promising in preclinical – It is the only bottled water without microplastics according to a study. you will no longer buy it by chance – Even Faustine Bollaert adopted this tip that helps keep the line after 40 years – Better than almond, this new nut is full of magnesium and cuts hunger – A genomic test to predict the response to chemotherapy?.
Further reading: Victims of a stroke in their twenties, Elise and Louis fall in love and commit to disability – Can it be dangerous for your health? – GSK requests the approval of the FDA to expand the use of its VRS vaccine to adults at risk from 18 to 49 years – Arboviroses under close surveillance | The doctor’s daily life | Medical news – Here is why exercise can fight the effects of aging.